Key result
Adenotonsillectomy reverses severe pulmonary hypertension and right heart failure in pediatric OSA.
Why the study?
While adenotonsillar hypertrophy-induced obstructive sleep apnea is common in children, its progression to World Health Organization Group III pulmonary hypertension and right heart failure is rare (<5% in literature) but potentially life-threatening.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Adenotonsillar hypertrophy-induced obstructive sleep apnea is a rare (<5%) but potentially reversible cause of severe pediatric pulmonary hypertension and right heart failure.
Obstructive sleep apnea (OSA) affects approximately 2%–3% of the pediatric population, with adenotonsillar hypertrophy (ATH) recognized as the predominant anatomical etiology, especially in otherwise healthy children. While ATH-induced OSA is common, its progression to pulmonary hypertension (PH, World Health Organization Group III) and right heart failure is rare (<5% in literature) but potentially life-threatening. We present the case of severe PH and right heart failure secondary to ATH, highlighting the dramatic reversibility following adenotonsillectomy. PH is a serious condition with diverse etiologies. This case underscores the importance of thorough clinical history and comprehensive physical examination in identifying treatable causes of PH.
No takes yet. Share an insight, caveat, or question.
Tomar et al. (2026) conducted a case report in Severe pulmonary hypertension (WHO Group III) and right heart failure secondary to adenotonsillar hypertrophy-induced obstructive sleep apnea (n=1). Adenotonsillectomy was evaluated on Reversibility of severe pulmonary hypertension and right heart failure. Adenotonsillectomy resulted in dramatic reversibility of severe pulmonary hypertension and right heart failure in a child with adenotonsillar hypertrophy-induced OSA.
Synapse has enriched 10 related papers. Consider them for comparative context: